Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

372 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Evolution of DNA repair defects during malignant progression of low-grade gliomas after temozolomide treatment.
van Thuijl HF, Mazor T, Johnson BE, Fouse SD, Aihara K, Hong C, Malmström A, Hallbeck M, Heimans JJ, Kloezeman JJ, Stenmark-Askmalm M, Lamfers ML, Saito N, Aburatani H, Mukasa A, Berger MS, Söderkvist P, Taylor BS, Molinaro AM, Wesseling P, Reijneveld JC, Chang SM, Ylstra B, Costello JF. van Thuijl HF, et al. Among authors: wesseling p. Acta Neuropathol. 2015 Apr;129(4):597-607. doi: 10.1007/s00401-015-1403-6. Epub 2015 Feb 28. Acta Neuropathol. 2015. PMID: 25724300 Free PMC article.
Molecular diagnostics of gliomas: state of the art.
Riemenschneider MJ, Jeuken JW, Wesseling P, Reifenberger G. Riemenschneider MJ, et al. Among authors: wesseling p. Acta Neuropathol. 2010 Nov;120(5):567-84. doi: 10.1007/s00401-010-0736-4. Epub 2010 Aug 17. Acta Neuropathol. 2010. PMID: 20714900 Free PMC article. Review.
Presence of an oligodendroglioma-like component in newly diagnosed glioblastoma identifies a pathogenetically heterogeneous subgroup and lacks prognostic value: central pathology review of the EORTC_26981/NCIC_CE.3 trial.
Hegi ME, Janzer RC, Lambiv WL, Gorlia T, Kouwenhoven MC, Hartmann C, von Deimling A, Martinet D, Besuchet Schmutz N, Diserens AC, Hamou MF, Bady P, Weller M, van den Bent MJ, Mason WP, Mirimanoff RO, Stupp R, Mokhtari K, Wesseling P; European Organisation for Research and Treatment of Cancer Brain Tumour and Radiation Oncology Groups; National Cancer Institute of Canada Clinical Trials Group. Hegi ME, et al. Among authors: wesseling p. Acta Neuropathol. 2012 Jun;123(6):841-52. doi: 10.1007/s00401-011-0938-4. Epub 2012 Jan 15. Acta Neuropathol. 2012. PMID: 22249618 Free article.
Genetics and pharmacogenomics of diffuse gliomas.
van Thuijl HF, Ylstra B, Würdinger T, van Nieuwenhuizen D, Heimans JJ, Wesseling P, Reijneveld JC. van Thuijl HF, et al. Among authors: wesseling p. Pharmacol Ther. 2013 Jan;137(1):78-88. doi: 10.1016/j.pharmthera.2012.09.002. Epub 2012 Sep 14. Pharmacol Ther. 2013. PMID: 22985521 Review.
Clinical value of chromosome arms 19q and 11p losses in low-grade gliomas.
Alentorn A, van Thuijl HF, Marie Y, Alshehhi H, Carpentier C, Boisselier B, Laigle-Donadey F, Mokhtari K, Scheinin I, Wesseling P, Ylstra B, Capelle L, Hoang-Xuan K, Sanson M, Delattre JY, Reijneveld JC, Idbaih A. Alentorn A, et al. Among authors: wesseling p. Neuro Oncol. 2014 Mar;16(3):400-8. doi: 10.1093/neuonc/not227. Epub 2013 Dec 12. Neuro Oncol. 2014. PMID: 24335697 Free PMC article.
DNA copy number analysis of fresh and formalin-fixed specimens by shallow whole-genome sequencing with identification and exclusion of problematic regions in the genome assembly.
Scheinin I, Sie D, Bengtsson H, van de Wiel MA, Olshen AB, van Thuijl HF, van Essen HF, Eijk PP, Rustenburg F, Meijer GA, Reijneveld JC, Wesseling P, Pinkel D, Albertson DG, Ylstra B. Scheinin I, et al. Among authors: wesseling p. Genome Res. 2014 Dec;24(12):2022-32. doi: 10.1101/gr.175141.114. Epub 2014 Sep 18. Genome Res. 2014. PMID: 25236618 Free PMC article.
Spatial and temporal evolution of distal 10q deletion, a prognostically unfavorable event in diffuse low-grade gliomas.
van Thuijl HF, Scheinin I, Sie D, Alentorn A, van Essen HF, Cordes M, Fleischeuer R, Gijtenbeek AM, Beute G, van den Brink WA, Meijer GA, Havenith M, Idbaih A, Hoang-Xuan K, Mokhtari K, Verhaak RG, van der Valk P, van de Wiel MA, Heimans JJ, Aronica E, Reijneveld JC, Wesseling P, Ylstra B. van Thuijl HF, et al. Among authors: wesseling p. Genome Biol. 2014 Sep 23;15(9):471. doi: 10.1186/s13059-014-0471-6. Genome Biol. 2014. PMID: 25245118 Free PMC article.
IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II-III diffuse gliomas.
Olar A, Wani KM, Alfaro-Munoz KD, Heathcock LE, van Thuijl HF, Gilbert MR, Armstrong TS, Sulman EP, Cahill DP, Vera-Bolanos E, Yuan Y, Reijneveld JC, Ylstra B, Wesseling P, Aldape KD. Olar A, et al. Among authors: wesseling p. Acta Neuropathol. 2015 Apr;129(4):585-96. doi: 10.1007/s00401-015-1398-z. Epub 2015 Feb 21. Acta Neuropathol. 2015. PMID: 25701198 Free PMC article.
Liquid biopsies in patients with diffuse glioma.
Best MG, Sol N, Zijl S, Reijneveld JC, Wesseling P, Wurdinger T. Best MG, et al. Among authors: wesseling p. Acta Neuropathol. 2015 Jun;129(6):849-65. doi: 10.1007/s00401-015-1399-y. Epub 2015 Feb 27. Acta Neuropathol. 2015. PMID: 25720744 Free PMC article.
Landscape of chromosomal copy number aberrations in gangliogliomas and dysembryoplastic neuroepithelial tumours.
Prabowo AS, van Thuijl HF, Scheinin I, Sie D, van Essen HF, Iyer AM, Spliet WG, Ferrier CH, van Rijen PC, Veersema TJ, Thom M, Schouten-van Meeteren AY, Reijneveld JC, Ylstra B, Wesseling P, Aronica E. Prabowo AS, et al. Among authors: wesseling p. Neuropathol Appl Neurobiol. 2015 Oct;41(6):743-55. doi: 10.1111/nan.12235. Epub 2015 May 19. Neuropathol Appl Neurobiol. 2015. PMID: 25764012
372 results